Press releases and statements

Spinraza SMA treatment

Muscular Dystrophy UK responds to Spinraza developers’ Breakthrough prize

Nic Bungay, Director of Campaigns, Care and Information at Muscular Dystrophy UK: “SMA is a life-limiting rare condition and patients desperately need access to Spinraza – the first and only treatment for this devastating condition....

Read more
Keep in touch
X
- Enter Your Location -
- or -